Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists. Second. vyd. [s.l.] : John Wiley & Sons, Inc., March 2013. ISBN 978-1-118-48813-3. DOI:10.1002/9781118540398.ch1 Why Enzymes as Drug Targets? Enzyme are Essential for Life, s. 1–23.
Control and regulation of pathways via negative feedback. Journal of the Royal Society, Interface, February 2017, s. 1–13. DOI: 10.1098/rsif.2016.0848. PMID 28202588.
Explicit Treatment of Non-Michaelis-Menten and Atypical Kinetics in Early Drug Discovery*. ChemMedChem, March 2021, s. 899–918. DOI: 10.1002/cmdc.202000791. PMID 33231926.
Control and regulation of pathways via negative feedback. Journal of the Royal Society, Interface, February 2017, s. 1–13. DOI: 10.1098/rsif.2016.0848. PMID 28202588.
Explicit Treatment of Non-Michaelis-Menten and Atypical Kinetics in Early Drug Discovery*. ChemMedChem, March 2021, s. 899–918. DOI: 10.1002/cmdc.202000791. PMID 33231926.